Possible Chlamydia vaccine target found

Sep 12, 2007

U.S. scientists have identified a potential target for a vaccine to fight Chlamydia -- the world's most prevalent sexually transmitted bacterial infection.

Researchers at the University of Pittsburgh Medical Center's Children's Hospital, led by Dr. Toni Darville, identified a plasmid-deficient strain of Chlamydia trachomatis that, when investigated in an animal model of genital tract infection, failed to cause disease. Plasmids are small molecules of DNA.

"This finding represents a major step forward in our work to eventually develop a vaccine against chlamydial disease," said Darville, a professor of pediatrics and microbiology/immunology. "If we can identify plasmid-deficient derivatives of the C. trachomatis strains that infect humans, they would have the potential to serve as a vaccine against this disease."

The study is reported in the Journal of Immunology.

Copyright 2007 by United Press International

Explore further: Don't let chronic heartburn spoil your Thanksgiving feast

add to favorites email to friend print save as pdf

Related Stories

Form Devices team designs Point as a house sitter

16 hours ago

A Scandinavian team "with an international outlook" and good eye for electronics, software and design aims to reach success with what they characterize as "a softer take" on home security. Their device is ...

Man pleads guilty in New York cybercrime case

19 hours ago

A California man has pleaded guilty in New York City for his role marketing malware that federal authorities say infected more than a half-million computers worldwide.

Recommended for you

Don't let chronic heartburn spoil your Thanksgiving feast

12 minutes ago

(HealthDay) —Planning on seconds at Thanksgiving Day dinner this year? If you suffer from chronic heartburn—clinically known as gastroesophageal reflux disease (GERD)—a few steps may help minimize the ...

Long wait yet for Ebola vaccine: experts

3 hours ago

It will be months, at least, before a vaccine becomes available to tackle Ebola, experts said Thursday as researchers reported success in early, safety tests with a leading candidate.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.